A Randomized, Head-to-Head, Single-Blind Study to Compare the Efficacy and Safety of Subcutaneous Abatacept Versus Subcutaneous Adalimumab, Both With Background Methotrexate, in Biologic-Naive Subjects With Rheumatoid Arthritis
A Randomized, Head-to-Head, Single-Blind Study to Compare the Efficacy and Safety of Subcutaneous Abatacept Versus Subcutaneous Adalimumab, Both With Background Methotrexate, in Biologic-Naive Subjects With Rheumatoid Arthritis
The purpose of this study is demonstrate that subcutaneous abatacept is non-inferior (no worse than) to subcutaneous adalimumab in the treatment of subjects with rheumatoid arthritis who are biologic naive
Inclusion Criteria:
Exclusion Criteria:
Asheville, North Carolina 28803, United States
Ciudad Autonoma de Beunos Aire, Buenos Aires 1431, Argentina
Ciudad Autonoma de Buenos Aire, Buenos Aires 1015, Argentina
Ciudad Autonoma de Buenos Aire, Buenos Aires C1428DQG, Argentina
Ciudad Autonoma, Buenos Aires CP1425A WC, Argentina